A Randomized, Single Blind Study to Investigate the PK, Relative Bioavailability and Safety of INL-001 Bupivacaine HCl Collagen-Matrix Implant 300 mg Compared to Marcaine™ 0.25% (Bupivacaine HCl) 175 mg Infiltration After Open Hernioplasty
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2017
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Innocoll
- 04 Oct 2017 Status changed from recruiting to completed.
- 17 Aug 2017 Planned primary completion date changed from 2 Aug 2017 to 30 Aug 2017.
- 02 Aug 2017 New trial record